Oral cancer theranostic application of feau bimetallic nanoparticles conjugated with MMP-1 antibody

Meng Tsan Tsai, Ying Sui Sun, Murugan Keerthi, Asit Kumar Panda, Udesh Dhawan, Yung Hsiang Chang, Chih Fang Lai, Michael Hsiao, Huey Yuan Wang, Ren Jei Chung

研究成果: 雜誌貢獻文章同行評審

4 引文 斯高帕斯(Scopus)


Metastatic oral squamous cell carcinoma (SCC) displays a poor disease prognosis with a 5-year survival rate of 39%. Chemotherapy has emerged as the mainstream treatment against small clusters of cancer cells but poses more risks than benefits for metastatic cells due to the non-specificity and cytotoxicity. To overcome these obstacles, we conjugated antibodies specific for matrix metalloproteinase-1 (MMP-1), a prognostic biomarker of SCC, to iron–gold bimetallic nanoparticles (FeAu NPs) and explored the capability of this complex to target and limit SSC cell growth via magnetic field-induced hyperthermia. Our results showed that 4.32 ± 0.79 nm sized FeAu NPs were superparamagnetic in nature with a saturation magnetization (Ms) of 5.8 emu/g and elevated the media temperature to 45◦C, confirming the prospect to deliver hyperthermia. Furthermore, conjugation with MMP-1 antibodies resulted in a 3.07-fold higher uptake in HSC-3 (human tongue squamous cell carcinoma) cells as compared to L929 (fibroblast) cells, which translated to a 5-fold decrease in cell viability, confirming SCC targeting. Finally, upon magnetic stimulation, MMP-1-FeAu NPs conjugate triggered 89% HSC-3 cellular death, confirming the efficacy of antibody-conjugated nanoparticles in limiting SCC growth. The synergistic effect of biomarker-specific antibodies and magnetic nanoparticle-induced hyperthermia may open new doors towards SCC targeting for improved disease prognosis.
出版狀態已發佈 - 1月 2022

ASJC Scopus subject areas

  • 化學工程 (全部)
  • 材料科學(全部)


深入研究「Oral cancer theranostic application of feau bimetallic nanoparticles conjugated with MMP-1 antibody」主題。共同形成了獨特的指紋。